Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Breaking News
U.S. Open scores: Here's the leaderboard for the 124th U.S. Open in Pinehurst
Program
On WRAL at 11 : Crispy summer weekend ahead. Find out how hot itâll be for Fatherâs Day and the timing for our only chance for rain
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hims & Hers Health Inc
(NY:
HIMS
)
24.37
+0.69 (+2.91%)
Official Closing Price
Updated: 7:00 PM EDT, Jun 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Hims & Hers Health Inc
< Previous
1
2
3
4
5
Next >
3 Sector Stars Lead Growth: Foot Locker, Shake Shack, Hims & Hers
June 10, 2024
These three stocks are looking to get a chunk of the total added jobs in the economy, meaning that analyst double-digit upside and growth projections are real
Via
MarketBeat
Topics
Economy
Exposures
Economy
MarketBeat Week in Review – 6/3 - 6/7
June 08, 2024
Equity markets shrugged off a much hotter-than-expected jobs report, but there could be more volatility after the next readings on inflation come out next week
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Hims & Hers Health Soars on Generic GLP-1 Rollout Plans
June 03, 2024
Him & Hers Health Inc. (NYSE: HIMS) provides a direct-to-consumer (DTC) health and wellness platform. The company was best known for prescribing treatments
Via
MarketBeat
Hims & Hers Health Inc. (NYSE: HIMS) Near the Top of Equities by Percentage Gain on 2/27
February 27, 2024
Via
Investor Brand Network
Call Option Volumes Spiked For These 3 Stocks
May 30, 2024
Option traders decided to plow into call contracts for these three stocks, investors can see the specific fundamental reasons behind this decision
Via
MarketBeat
LifeMD Can Surge on Its GLP-1 Offerings
May 28, 2024
LifeMD is a leading telehealth provider that investors should take note of; the company is entering the GLP-1 market, and its stock could soar as a result
Via
MarketBeat
Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers
May 20, 2024
From
Hims & Hers
Via
Business Wire
Hims & Hers Welcomes Anja Manuel, Foreign Policy Expert, Domestic Regulations Advisor, and Former Diplomat to its Board of Directors
May 16, 2024
From
Hims & Hers
Via
Business Wire
3 Stocks That Suddenly Drew in Options Traders
May 13, 2024
Three discounted stocks caught the attention of call option buyers last week, and they have Wall Street analysts to back them through double-digit upside.
Via
MarketBeat
Hims & Hers Health Stock Could Become a Wealth Compounder
May 07, 2024
Hims & Hers stock could give investors the best of both stability and double-digit upside through EPS projections and price targets, especially after 1Q24
Via
MarketBeat
Topics
Economy
Exposures
Economy
Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results
May 06, 2024
From
Hims & Hers Health, Inc.
Via
Business Wire
Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024
April 15, 2024
From
Hims & Hers Health, Inc.
Via
Business Wire
Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member
April 04, 2024
From
Hims & Hers Health, Inc.
Via
Business Wire
3 Stocks With Unusual Call Option Activity
March 26, 2024
Three stocks reported rising call option buying activity could see even higher prices soon. Analysts see the writing on the wall, and traders stampeded in
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
LifeMD Shares Come Back to Life on GLP-1 Business Growth
March 19, 2024
LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024
Via
MarketBeat
Can WeightWatchers Regain its Mojo after Oprah Steps Down?
March 13, 2024
WW International Inc. (NASDAQ: WW) (WeightWatchers) has had a disastrous 2024, with its shares collapsing 66.7% year-to-date (YTD).
Via
MarketBeat
Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024
March 11, 2024
From
Hims & Hers Health, Inc.
Via
Business Wire
Hims & Hers Stock Rises On Stimulating Earnings Growth
March 05, 2024
Telehealth platform Hims & Hers has turned the corner into GAAP profitability and is expanding its product portfolio to increase its addressable audience
Via
MarketBeat
bluebird bio stock is ripe for a 400% institutional short squeeze
February 27, 2024
Bluebird Bio stock could be on the verge of a 400% pop on earnings, management has set the writing on the wall for institutional buying to trickle in
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
February 26, 2024
From
Hims & Hers Health, Inc.
Via
Business Wire
This healthcare stock making a buzz with 160% growth
February 26, 2024
Healthcare stocks are typically on the boring side of the spectrum, that is until you add a bit of technology and the right niche to them.
Via
MarketBeat
Topics
Economy
Exposures
Economy
Hims & Hers Names Dan Kenger as the Company’s First Chief Design Officer
February 20, 2024
From
Hims & Hers Health, Inc.
Via
Business Wire
Hims & Hers to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
February 05, 2024
From
Hims & Hers Health, Inc.
Via
Business Wire
Hims & Hers Teams with Hartford HealthCare to Connect People to In-person Care
January 11, 2024
From
Hims & Hers Health, Inc.
Via
Business Wire
Weight Watchers gains from Oprah’s GLP-1 weight-loss
January 02, 2024
Oprah Winfrey revealed she has lost over 60 pounds and is on the path to reaching her weight goal of 167 lbs. She credits this to taking GLP-1 medication
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
LifeMD expands telehealth GLP-1weight-loss service with Medifast
December 19, 2023
LifeMD Inc. (NASDAQ: LFMD) is a direct-to-consumer (DTC) comprehensive virtual healthcare platform. The company offers per-visit and membership plan pricing
Via
MarketBeat
Ozempic vs. Mounjaro:: Battle of the bulge
December 04, 2023
The year 2023 was a breakout year for glucagon-like peptide (GLP-1) weight-loss drugs, led by the popularity of Ozempic. Celebrity usage
Via
MarketBeat
Exposures
Product Safety
Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and Loss
December 04, 2023
From
Hims & Hers Health, Inc.
Via
Business Wire
Hims & Hers earnings highlight expanded personalized treatments
November 29, 2023
E-health and wellness platform operator Hims & Hers Inc. reported a stellar quarter of growth that highlighted its expanded line of personalized products
Via
MarketBeat
Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Outlook
November 06, 2023
From
Hims & Hers Health, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.